Patents by Inventor Valerie Mary Corrigall

Valerie Mary Corrigall has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Novel Protein With Anti-Inflammatory Properties
    Publication number: 20210238239
    Abstract: The present invention provides an isolated or recombinant protein consisting of the amino acid sequence according to SEQ ID NO: 3 or SEQ ID: NO: 4 and its use in the prevention or treatment of an inflammatory condition.
    Type: Application
    Filed: October 31, 2020
    Publication date: August 5, 2021
    Applicant: IMMUNE REGULATION LIMITED
    Inventors: Valerie Mary Corrigall, Gabriel Stavros Panayi
  • Protein with anti-inflammatory properties
    Patent number: 10858409
    Abstract: The present invention provides an isolated or recombinant protein consisting of the amino acid sequence according to SEQ ID NO: 3 or SEQ ID: NO: 4 and its use in the prevention or treatment of an inflammatory condition.
    Type: Grant
    Filed: June 13, 2018
    Date of Patent: December 8, 2020
    Assignee: IMMUNE REGULATION LIMITED
    Inventors: Valerie Mary Corrigall, Gabriel Stavros Panayi
  • Novel Protein With Anti-Inflammatory Properties
    Publication number: 20190382457
    Abstract: The present invention provides an isolated or recombinant protein consisting of the amino acid sequence according to SEQ ID NO: 3 or SEQ ID: NO: 4 and its use in the prevention or treatment of an inflammatory condition.
    Type: Application
    Filed: June 13, 2018
    Publication date: December 19, 2019
    Inventors: Valerie Mary Corrigall, Gabriel Stavros Panayi
  • Use of BiP or a variant, homologue, derivative or fragment thereof in the manufacture of a medicament for the prevention or treatment of bone loss or bone resorption
    Patent number: 8076293
    Abstract: The present invention relates to the use of BiP or a variant, homologue, derivative or fragment thereof in the manufacture of a medicament for the prevention or treatment of bone loss or bone resorption.
    Type: Grant
    Filed: April 18, 2006
    Date of Patent: December 13, 2011
    Inventors: Gabriel Stavros Panayi, Valerie Mary Corrigall
  • Use of BiP or a Variant, Homologue, Derivative or Fragment Thereof in the Manufacture of a Medicament for the Prevention or Treatment of Bone Loss or Bone Resorption
    Publication number: 20090281026
    Abstract: The present invention relates to the use of BiP or a variant, homologue, derivative or fragment thereof in the manufacture of a medicament for the prevention or treatment of bone loss or bone resorption.
    Type: Application
    Filed: April 18, 2006
    Publication date: November 12, 2009
    Applicant: King's College London
    Inventors: Gabriel Stavros Panayi, Valerie Mary Corrigall
  • Treatment of inflammatory disease
    Patent number: 6995240
    Abstract: The immunoglobulin heavy chain binding protein BiP(GRP78), or a fragment thereof, provides a reagent for indicating the presence of rheumatoid arthritis (RA). The protein used is a recombinant BiP(GRP78) having a defined sequence. A prognostic and/or diagnostic test for RA may be an ELISA or a Western Blot that utilizes the BiP(GRP78) protein or a fragment thereof. Also disclosed are a method of testing for RA using BiP(GRP78) or a cDNA sequence coding therefor. Further disclosed is a method of treating RA by the BiP(GRP78) protein or corresponding cDNA.
    Type: Grant
    Filed: October 8, 1999
    Date of Patent: February 7, 2006
    Assignee: King's College London
    Inventors: Gabriel Stavros Panayi, Valerie Mary Corrigall, Mark Duncan Bodman-Smith, Mark Stewart Fife, Jeremy Shaun Lanchbury